| PKC and the control of localized signal dynamics C Rosse, M Linch, S Kermorgant, AJM Cameron, K Boeckeler, PJ Parker Nature reviews Molecular cell biology 11 (2), 103-112, 2010 | 547 | 2010 |
| Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency CD Hurst, O Alder, FM Platt, A Droop, LF Stead, JE Burns, GJ Burghel, ... Cancer cell 32 (5), 701-715. e7, 2017 | 272 | 2017 |
| The regulated assembly of a PKCɛ complex controls the completion of cytokinesis AT Saurin, J Durgan, AJ Cameron, A Faisal, MS Marber, PJ Parker Nature cell biology 10 (8), 891-901, 2008 | 158 | 2008 |
| Membrane tension orchestrates rear retraction in matrix-directed cell migration JHR Hetmanski, H de Belly, I Busnelli, T Waring, RV Nair, V Sokleva, ... Developmental cell 51 (4), 460-475. e10, 2019 | 143 | 2019 |
| PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity AJM Cameron, C Escribano, AT Saurin, B Kostelecky, PJ Parker Nature structural & molecular biology 16 (6), 624-630, 2009 | 140 | 2009 |
| mTORC2 targets AGC kinases through Sin1-dependent recruitment AJM Cameron, MD Linch, AT Saurin, C Escribano, PJ Parker Biochemical Journal 439 (2), 287-297, 2011 | 99 | 2011 |
| Expression of Fc α/μ receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy KJ McDonald, AJM Cameron, JM Allen, AG Jardine Biochemical and biophysical research communications 290 (1), 438-442, 2002 | 99 | 2002 |
| Protein kinase C-β dictates B cell fate by regulating mitochondrial remodeling, metabolic reprogramming, and heme biosynthesis C Tsui, N Martinez-Martin, M Gaya, P Maldonado, M Llorian, NM Legrave, ... Immunity 48 (6), 1144-1159. e5, 2018 | 92 | 2018 |
| PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival AJ Cameron, KJ Procyk, M Leitges, PJ Parker International journal of cancer 123 (4), 769-779, 2008 | 80 | 2008 |
| Fluvastatin inhibits raft dependent Fcγ receptor signalling in human monocytes DZ Hillyard, AG Jardine, KJ McDonald, AJM Cameron Atherosclerosis 172 (2), 219-228, 2004 | 78 | 2004 |
| A molecular switch changes the signalling pathway used by the FcγRI antibody receptor to mobilise calcium A Melendez, RA Floto, AJ Cameron, DJ Gillooly, MM Harnett, JM Allen Current biology 8 (4), 210-222, 1998 | 78 | 1998 |
| Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease DZ Hillyard, AJM Cameron, KJ McDonald, J Thomson, A MacIntyre, ... Atherosclerosis 175 (2), 305-313, 2004 | 75 | 2004 |
| Isolation and cloning of a protein-serine/threonine phosphatase from an archaeon J Leng, AJ Cameron, S Buckel, PJ Kennelly Journal of bacteriology 177 (22), 6510-6517, 1995 | 64 | 1995 |
| Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface J Claus, G Patel, F Autore, A Colomba, G Weitsman, TN Soliman, ... Elife 7, e32271, 2018 | 61 | 2018 |
| Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation DZ Hillyard, CD Nutt, J Thomson, KJ McDonald, RK Wan, AJM Cameron, ... Atherosclerosis 191 (2), 319-325, 2007 | 49 | 2007 |
| Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin DZ Hillyard, AJM Cameron, AH McIntyre, MH Hadden, HE Marshall, ... Clinical and experimental pharmacology and physiology 29 (8), 673-678, 2002 | 48 | 2002 |
| Knockout of the PKN family of Rho effector kinases reveals a non-redundant role for PKN2 in developmental mesoderm expansion I Quetier, JJT Marshall, B Spencer-Dene, S Lachmann, A Casamassima, ... Cell reports 14 (3), 440-448, 2016 | 47 | 2016 |
| Protein kinases, from B to C AJ Cameron, M De Rycker, V Calleja, D Alcor, S Kjaer, B Kostelecky, ... Biochemical Society Transactions 35 (5), 1013-1017, 2007 | 46 | 2007 |
| Opposing roles for ADAMTS2 and ADAMTS14 in myofibroblast differentiation and function EP Carter, KK Yoneten, N Gavara, EJ Tyler, V Gauthier, ER Murray, ... The Journal of Pathology 262 (1), 90-104, 2024 | 44 | 2024 |
| Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion ER Murray, S Menezes, JC Henry, JL Williams, L Alba-Castellón, ... Cell Reports 38 (4), 2022 | 44 | 2022 |
